Literature DB >> 19042181

Powerful mutators lurking in the genome.

Vincent Petit1, Jean-Pierre Vartanian, Simon Wain-Hobson.   

Abstract

The human genome encodes numerous enzymes capable of deaminating polynucleotides. While they are capable of exquisite specificity, occasionally they result in hypermutation where up to 90 per cent of cytidine or adenosine residues may be edited. As such, they constitute a formidable anti-viral barrier, for no virus can survive such a high mutation rate. As the APOBEC3 group of cytidine deaminases edit single-stranded viral DNA, the crucial question is can they hyperedit chromosomal DNA? Everything points to a positive answer. Nonetheless, hypermutants per se have not yet been described, probably being countered by highly efficient mismatch repair. For the APOBEC3 genes, not only is their physiological function unknown, but also their role in the induction of cancer remains to be determined. Yet given the pace of research, all this is certain to change in the next few years.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19042181      PMCID: PMC2660927          DOI: 10.1098/rstb.2008.0272

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  102 in total

1.  G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.

Authors:  Tara L Kieffer; Patty Kwon; Richard E Nettles; Yefei Han; Stuart C Ray; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses.

Authors:  Cécile Esnault; Odile Heidmann; Frédéric Delebecque; Marie Dewannieux; David Ribet; Allan J Hance; Thierry Heidmann; Olivier Schwartz
Journal:  Nature       Date:  2005-01-27       Impact factor: 49.962

3.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

4.  G to A hypermutation of hepatitis B virus.

Authors:  Chiemi Noguchi; Hiromi Ishino; Masataka Tsuge; Yoshifumi Fujimoto; Michio Imamura; Shoichi Takahashi; Kazuaki Chayama
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

5.  APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.

Authors:  April J Schumacher; Dwight V Nissley; Reuben S Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

6.  Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.

Authors:  Brian P Doehle; Alexandra Schäfer; Heather L Wiegand; Hal P Bogerd; Bryan R Cullen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Is abundant A-to-I RNA editing primate-specific?

Authors:  Eli Eisenberg; Sergey Nemzer; Yaron Kinar; Rotem Sorek; Gideon Rechavi; Erez Y Levanon
Journal:  Trends Genet       Date:  2005-02       Impact factor: 11.639

8.  The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage.

Authors:  A D J Scadden
Journal:  Nat Struct Mol Biol       Date:  2005-05-15       Impact factor: 15.369

9.  Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.

Authors:  Rodolphe Suspène; Denise Guétard; Michel Henry; Peter Sommer; Simon Wain-Hobson; Jean-Pierre Vartanian
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

10.  Evolutionarily conserved human targets of adenosine to inosine RNA editing.

Authors:  Erez Y Levanon; Martina Hallegger; Yaron Kinar; Ronen Shemesh; Kristina Djinovic-Carugo; Gideon Rechavi; Michael F Jantsch; Eli Eisenberg
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

View more
  12 in total

1.  Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution.

Authors:  Shai Carmi; George M Church; Erez Y Levanon
Journal:  Nat Commun       Date:  2011-11-01       Impact factor: 14.919

2.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

3.  The 30th anniversary of quasispecies. Meeting on 'Quasispecies: past, present and future'.

Authors:  Esteban Domingo; Simon Wain-Hobson
Journal:  EMBO Rep       Date:  2009-04-03       Impact factor: 8.807

4.  Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.

Authors:  Beth K Thielen; John P McNevin; M Juliana McElrath; Brook Vander Stoep Hunt; Kevin C Klein; Jaisri R Lingappa
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

Review 5.  Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study.

Authors:  Bogdan I Fedeles; John M Essigmann
Journal:  DNA Repair (Amst)       Date:  2018-08-25

6.  An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals.

Authors:  Carsten Münk; Anouk Willemsen; Ignacio G Bravo
Journal:  BMC Evol Biol       Date:  2012-05-28       Impact factor: 3.260

7.  Promoters of Escherichia coli versus promoter islands: function and structure comparison.

Authors:  Valeriy V Panyukov; Olga N Ozoline
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

8.  APOBEC3 inhibits DEAD-END function to regulate microRNA activity.

Authors:  Sara Ali; Namrata Karki; Chitralekha Bhattacharya; Rui Zhu; Donna A MacDuff; Mark D Stenglein; April J Schumacher; Zachary L Demorest; Reuben S Harris; Angabin Matin; Sita Aggarwal
Journal:  BMC Mol Biol       Date:  2013-07-26       Impact factor: 2.946

9.  Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.

Authors:  Bianka Mussil; Rodolphe Suspène; Marie-Ming Aynaud; Anne Gauvrit; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.

Authors:  Serena Nik-Zainal; David C Wedge; Ludmil B Alexandrov; Mia Petljak; Adam P Butler; Niccolo Bolli; Helen R Davies; Stian Knappskog; Sancha Martin; Elli Papaemmanuil; Manasa Ramakrishna; Adam Shlien; Ingrid Simonic; Yali Xue; Chris Tyler-Smith; Peter J Campbell; Michael R Stratton
Journal:  Nat Genet       Date:  2014-04-13       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.